Iodine Software Wins 2022 Best in KLAS for Clinical Documentation Integrity

 

As artificial intelligence permeates every industry, healthcare stands out as a sector with high stakes and an urgent need for innovation. Iodine Software, a healthcare AI company, has risen to this challenge, recently winning 2022 Best in KLAS for their outstanding work in Clinical Documentation Integrity (CDI).) The KLAS report annually recognizes excellence in software and services companies making a difference in improving patient care. CDI is a crucial patient care area where precise and comprehensive record-keeping can significantly affect patient outcomes.

How has Iodine Software achieved this level of excellence in a highly critical and complex field? What does it take to build an innovative platform that delivers value and garners respect and admiration from healthcare professionals, earning 2022 Best in KLAS recognition?

Welcome to Iodine Intelligence, hosted by Lauren Hickey. In this episode, Iodine’s William Chan, CEO and Co-Founder, and Tim O’Hara, former Vice President of Client Experience at Iodine Software, joined Hickey to discuss their recent 2022 Best in KLAS win and what it means to be a leader in clinical documentation integrity. They discuss:

  • The journey of Iodine Software from being an innovative product to becoming an innovative platform
  • The importance of validation from healthcare professionals who hold the company to a high standard
  • The values that Iodine upholds, with a focus on delivering a product that meets its promises and using customer feedback to improve continually

William Chan, the CEO, and Co-Founder of Iodine Software, has been a driving force behind the company’s innovative approach to healthcare AI. With a rich background in technology and a deep understanding of the healthcare industry, Chan has led Iodine to be a leader in clinical documentation integrity. Joining him is Tim O’Hara, the Vice President of Client Experience. O’Hara’s extensive experience in healthcare technology and client relations has been pivotal in ensuring that Iodine’s services meet and exceed the high standards set by healthcare professionals. Together, they have steered Iodine to a path of excellence, culminating in the recent 2022 Best in KLAS recognition for CDI.

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…